Akoh JA. Current management of autosomal dominant polycystic kidney disease. World J Nephrol. 2015; 4: 468. doi: 10.5527/wjn.v4.i4.468 PMID: 26380198
Sallée M, Rafat C, Zahar J-R, Paulmier B, Grünfeld J-P, Knebelmann B, et al. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2009; 4: 1183-1189. doi: 10.2215/CJN.01870309 PMID: 19470662
Fick GM, Johnson a M, Hammond WS, Gabow P a. Causes of death in autosomal dominant polycystic kidney disease. Jasn. 1995; 5: 2048-56. Available: http://www.ncbi.nlm.nih.gov/pubmed/7579053 PMID: 7579053
Piccoli GB, Arena V, Consiglio V, Deagostini M, Pelosi E, Douroukas A, et al. Positron emission tomography in the diagnostic pathway for intracystic infection in adpkd and "cystic" kidneys. a case series. BMC Nephrol. BioMed Central Ltd; 2011; 12: 48. doi: 10.1186/1471-2369-12-48
Lantinga M a., Drenth JPH, Gevers TJG. Diagnostic criteria in renal and hepatic cyst infection. Nephrol Dial Transplant. 2014; 1-8. doi: 10.1093/ndt/gfu227
Balbo BEP, Sapienza MT, Ono CR, Jayanthi SK, Dettoni JB, Castro I, et al. Cyst infection in hospitaladmitted autosomal dominant polycystic kidney disease patients is predominantly multifocal and associated with kidney and liver volume. Brazilian J Med Biol Res. 2014; 47: 584-593. doi: 10.1590/1414-431X20143584
Jouret F, Lhommel R, Devuyst O, Annet L, Pirson Y, Hassoun Z, et al. Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: Attributes and limitations of the current modalities. Nephrol Dial Transplant. 2012; 27: 3746-3751. doi: 10.1093/ndt/gfs352 PMID: 23114901
Bobot M, Ghez C, Gondouin B, Sallée M, Fournier PE, Burtey S, et al. Diagnostic performances of 18-FDG PET-CT in cyst infection in patients with autosomal dominant polycystic kidney disease. Clin Microbiol Infect. Elsevier Ltd; 2015; doi: 10.1016/j.cmi.2015.09.024
Suwabe T, Ubara Y, Sumida K, Hayami N, Hiramatsu R, Yamanouchi M, et al. Clinical features of cyst infection and hemorrhage in ADPKD: New diagnostic criteria. Clin Exp Nephrol. 2012; 16: 892-902. doi: 10.1007/s10157-012-0650-2 PMID: 22688273
Suwabe T, Ubara Y, Higa Y, Nakanishi S, Sogawa Y, Nomura K, et al. Infected Hepatic and Renal Cysts: Differential Impact on Outcome in Autosomal Dominant Polycystic Kidney Disease. Nephron Clin Pract. 2009; 112: c157-c163. Available: http://www.karger.com/DOI/10.1159/000214211 doi: 10.1159/000214211 PMID: 19390216
Kanaan N, Goffin E, Pirson Y, Devuyst O, Hassoun Z. Carbohydrate Antigen 19-9 as a Diagnostic Marker for Hepatic Cyst Infection in Autosomal Dominant Polycystic Kidney Disease. Am J Kidney Dis. 2010; 55: 916-922. doi: 10.1053/j.ajkd.2009.12.023 PMID: 20189277
Ichioka K, Saito R, Matsui Y, Terai A. Diffusion-Weighted Magnetic Resonance Imaging of Infected Renal Cysts in a Patient with Polycystic Kidney Disease. Urology. Elsevier; 2007; 70: 1219. doi: 10.1016/j.urology.2007.09.040
Bleeker-Rovers CP, de Sévaux RGL, van Hamersvelt HW, Corstens FHM, Oyen WJG. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am J kidney Dis Off J Natl Kidney Found. National Kidney Foundation, Inc.; 2003; 41: E18-21. doi: 10.1016/S0272-6386(03)00368-8
Jouret F, Lhommel R, Beguin C, Devuyst O, Pirson Y, Hassoun Z, et al. Positron-emission computed tomography in cyst infection diagnosis in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2011; 6: 1644-1650. doi: 10.2215/CJN.06900810 PMID: 21700816
Soussan M, Sberro R, Wartski M, Fakhouri F, Pecking A-P, Alberini J-L. Diagnosis and localization of renal cyst infection by 18F-fluorodeoxyglucose PET/CT in polycystic kidney disease. Ann Nucl Med. Springer Japan; 2008; 22: 529-531. doi: 10.1007/s12149-008-0150-3
Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, et al. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 2009; 20: 205-212. doi: 10.1681/ASN.2008050507 PMID: 18945943
Rule a. D. Comparison of Methods for Determining Renal Function Decline in Early Autosomal Dominant Polycystic Kidney Disease: The Consortium of Radiologic Imaging Studies of Polycystic Kidney Disease Cohort. J Am Soc Nephrol. 2006; 17: 854-862. doi: 10.1681/ASN.2005070697 PMID: 16452494
Cornec-Le Gall E, Audrezet M-P, Rousseau a., Hourmant M, Renaudineau E, Charasse C, et al. The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2015; 1-10. doi: 10.1681/ASN.2015010016
Torres VE, Grantham JJ, Chapman AB, Mrug M, Bae KT, King BF Jr., et al. Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2011; 6: 640-647. doi: 10.2215/CJN.03250410\nCJN.03250410 [pii] PMID: 21088290
Schrier RW, Brosnahan G, Cadnapaphornchai M a, Chonchol M, Friend K, Gitomer B, et al. Predictors of Autosomal Dominant Polycystic Kidney Disease Progression. J Am Soc Nephrol. 2014; 1-20. doi: 10.1681/ASN.2013111184
Elzinga LW, Golper TA, Rashad AL, Carr ME, Bennett WM. Ciprofloxacin activity in cyst fluid from polycystic kidneys. Antimicrob Agents Chemother. UNITED STATES; 1988; 32: 844-847.
Lantinga M a., Geudens a., Gevers TJG, Drenth JPH. Systematic review: the management of hepatic cyst infection. Aliment Pharmacol Ther. 2015; 41: 253-261. doi: 10.1111/apt.13047 PMID: 25496117
Telenti A, Torres VE, Gross JBJ, Van Scoy RE, Brown ML, Hattery RR. Hepatic cyst infection in autosomal dominant polycystic kidney disease. Mayo Clin Proc. UNITED STATES; 1990; 65: 933-942.
Lantinga M a., De Sévaux RGL, Drenth JPH. 18F-FDG PET/CT during diagnosis and follow-up of recurrent hepatic cyst infection in autosomal dominant polycystic kidney disease. Clin Nephrol. 2015; 84 (2015): 61-64. doi: 10.5414/CN108495
Desouza RM, Prachalias A, Srinivasan P, O'Doherty M, Olsburgh J. Differentiation between infection in kidney and liver cysts in autosomal dominant polycystic kidney disease: use of PET-CT in diagnosis and to guide management. Transplant Proc. Elsevier Inc.; 2009; 41: 1942-5. doi: 10.1016/j. transproceed.2008.10.102
Kaim a H, Burger C, Ganter CC, Goerres GW, Kamel E, Weishaupt D, et al. PET-CT-guided percutaneous puncture of an infected cyst in autosomal dominant polycystic kidney disease: case report. Radiology. 2001; 221: 818-21. doi: 10.1148/radiol.2213010445 PMID: 11719684
Meller J, Sahlmann C, Scheel AK. 18F-FDG PET and PET/CT in Fever of Unknown Origin. J Nucl Med. 2007; 48: 35-45. PMID: 17204697
Vaidyanathan S, Patel CN, Scarsbrook a. F, Chowdhury FU. FDG PET/CT in infection and inflammation - current and emerging clinical applications. Clin Radiol. The Royal College of Radiologists; 2015; 70: 787-800. doi: 10.1016/j.crad.2015.03.010
Lovinfosse P, Weekers L, Bonvoisin C, Bovy C, Grosch S, Krzesinski J-M, et al. Fluorodeoxyglucose F 18 Positron Emission Tomography Coupled With Computed Tomography in Suspected Acute Renal Allograft Rejection. Am J Transplant. 2015; n/a-n/a. doi: 10.1111/ajt.13429
Gans SL, Pols M a., Stoker J, Boermeester M a. Guideline for the Diagnostic Pathway in Patients with Acute Abdominal Pain. Dig Surg. 2015; 23-31. doi: 10.1159/000371583 PMID: 25659265
